Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
Size
11-50 employees
Stage
Other
founded in
2018
Deep Cure is a Boston-based biotech company focused on developing small molecule therapeutics for immune diseases using its AI-powered drug discovery platform. The company collaborates with leading researchers and has made significant advancements, including the development of its first candidate, DC-9476, targeting multiple autoimmune diseases such as rheumatoid arthritis. Deep Cure differentiates itself by leveraging AI to tackle historically challenging drug targets, aiming for true novelty in drug development. With a strong pipeline and collaborations, the company is positioned to address significant unmet medical needs in the therapeutic landscape.
Something looks off?